PICC Lines for OPAT in patients with substance abuse disorder

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org

1 post / 0 new
Michael Hayes
Michael Hayes's picture
Offline
Last seen: 21 hours 28 min ago
Joined: 01/09/2020 - 12:26
PICC Lines for OPAT in patients with substance abuse disorder

We are getting specific requests from hospital leadership about reviewing length of stay for patients requiring long term antibiotic therapy and if there are other opportunities. Currently, most patients remain in the hospital due to the potential of IV access promoting ease of administration and/or infection risks.

Inquiring to see if any institutions have specific guidelines/policies for long term IV access in patients with known substance abuse disorder who are known to inject drugs. The ISDA guidelines state each patient should be treated on a case by case basis (see below and attached).

Thanks in advance for responses if you have any guidance.

III. Can persons who inject drugs (PWID) be treated with OPAT at home?
Recommendation
3. No recommendation can be made about whether PWID
may be treated with OPAT at home (no recommendation,
low-quality evidence). Decisions should be made on a caseby-
case basis.

CID 2019:68 (1 January) • Norris et al

Attach files :